Skip to main content
Loading...

Our Articles and Knowledge Base

Bio Meds

View Biomeds Products

28Sep

Radiation-Associated Coronary Disease in Young Cancer Survivors

  • Radiation-Associated Coronary Disease

The article “Radiation-Associated Coronary Disease in Young Cancer Survivors” highlights important developments in radiotherapy (RT) research in reducing and evaluating coronary artery disease (CAD). Many significant findings have surfaced from well-executed research studies, evolving the therapeutic landscape and changing how we treat and monitor breast cancer patients post-RT.

27Sep

Evaluation of Sublingual Microcirculation for weaning from VA ECMO

  • Evaluation of Sublingual Microcirculation for weaning from VA  ECMO

This study aims to test the effectiveness of microcirculatory imaging in a similar sublingual spot that uses dark incident field (IDF) imaging to assess successful weaning from VA-ECMO and compare IDF imaging to echocardiographic factors. According to the authors, there is increased incorporation of Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in the treatment of cardiogenic shock (CS). The marker success is still largely unknown (Akin et al., 2017).

26Sep

Novel Surfaces in Extracorporeal Membrane Oxygenation Circuits

  • Novel Surfaces in Extracorporeal Membrane Oxygenation Circuits

It's difficult to strike a balance between systemic anticoagulation and clotting. The endothelium manages the equilibrium between anticoagulant and prothrombotic systems in proper hemostasis. Because of the blood-surface interaction during ECLS, systemic anticoagulation is required to reduce the risk of clotting. UNFH has a short half-life, is easy to titrate at the bedside, and is reversible with protamine.

25Sep

Veno‐Arterial Extracorporeal Membrane Oxygenation

  • ECMO

Percutaneous veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) is a resource used in treating patients with cardiogenic shock. The protocols of weaning from the VA‐ECMO are not yet well defined. The research carried out from the past few years shows that the weaning rate from VA‐ECMO is still low, but research shows that there is a higher potential of increasing the rate in the next few years.

23Sep

Vein graft patency after coronary artery bypass graft surgery

  • Vein graft

Graft patency is significant in determining the long-term medical success after coronary artery bypass graft surgery (CABG). Saphenous vein graft (SVG) continues to be the most usual conduit in CABG.  Compared to the conventional (CON) SVG technique, the atraumatic No Touch (NT) of harvesting the SVG with its pedicle intact has proven to be more effective in the histological and biochemical aspects of the NT SVG.